Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-Arm, Open-Label Phase 2 Study of Once-Weekly Foscenvivint in Patients With Liver Cirrhosis Due to HIV/HCV Co-infection in the Setting of Hemophilia

NCT07681089 is registered in ClinicalTrials.gov with Kiminori Kimura, MD as lead sponsor.

NCT NCT07681089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07681089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-Arm, Open-Label Phase 2 Study of Once-Weekly Foscenvivint in Patients With Liver Cirrhosis Due to HIV/HCV Co-infection in the Setting of Hemophilia
Lead sponsor
Kiminori Kimura, MD
Phase
Phase 2
Overall status
Recruiting
Start date
October 1, 2026
Completion date
March 31, 2028
Enrollment
7 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis